Ajay J. Kirtane, MD, Associate Professor of Medicine at Columbia University Medical Center in New York, talks with DocWire News about clinical decision-making for patients presenting with angina, as well as how he approaches selecting the optimal treatment modalities for this patient population. According to Dr. Kirtane, the choice of modality ultimately depends greatly on the individual patient, their individual disease state and its severity, their personal preferences, whether they’re stable or unstable. Patients with milder forms of disease, medical therapy may be beneficial, while rapidly worsening symptoms may benefit from more invasive strategies.
Today's Top 5
5. Take Note, Interventionalists!
Many patients with #STEMI and cardiogenic shock do not receive #PCI quickly enough, which negatively affects mortality. Additional interventions are required to improve first-medical-contact-to-device times. https://t.co/tppryPApfM via @practiceupdate #cardiology pic.twitter.com/vxeSmwvGOo— Arie Blitz, MD, MBA (@ArieBlitzMD) October 17, 2018